FDA Approves New Pancreatic Cancer Treatment

Why it matters locally: This FDA approval provides a new treatment option for Mainers battling pancreatic cancer, a disease with a high mortality rate. Access to this new drug will depend on local healthcare providers and insurance coverage.

U.S. health officials approved a new drug for pancreatic cancer. The Food and Drug Administration (FDA) announced the approval, which introduces a different method for treating the illness. The drug functions by blocking a protein that contributes to tumor growth. This protein is present in most pancreatic cancer cases. The new treatment targets this specific mechanism.